155233-30-0(4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-)
Product Description
155233-30-0
CAS No.
155233-30-0
Chemical Name:
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
CBNumber:
CB81242757
Molecular Formula:
C23H35NOS
Formula Weight:
373.6
MOL File:
Mol file
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))- Synonyms:
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
curacin A
Thiazole, 4,5-dihydro-4-[(1Z,5E,7E,11R)-11-methoxy-8-methyl-1,5,7,13-tetradecatetraen-1-yl]-2-[(1R,2S)-2-methylcyclopropyl]-, (4R)-
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
Property
Boiling point:
471.7±45.0 °C(Predicted)
Density
1.01±0.1 g/cm3(Predicted)
pka
4.39±0.40(Predicted)
Safety
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
Suppliers
Global( 2)Suppliers
South Korea 1
United States 1
Global 2
Supplier
Tel
Email
Country
ProdList
Advantage
CHEMICAL LAND21
82- 2 -783 - 8063
sales21@chemicalland21.com
South Korea
6315
74
HONEST JOY HOLDINGS LIMITED
+86-755-26404303
sales@honestjoy.cn
United States
6702
54
155233-30-0(4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-)
Related Search:
4,5-Dihydro-4-(11-methoxy-8-methyl-1,5,7,13-tetradecatetraenyl)-2-(2-m ethylcyclopropyl)thiazole (1R-(1alpha(R*(1Z,5E,7E,11R*)),2alpha))-
curacin A
Thiazole, 4,5-dihydro-4-[(1Z,5E,7E,11R)-11-methoxy-8-methyl-1,5,7,13-tetradecatetraen-1-yl]-2-[(1R,2S)-2-methylcyclopropyl]-, (4R)-
155233-30-0
C23H35NOS
Copyright 2017 © ChemicalBook. All rights reserved